Market Research Report
Electrical Activity Testing (Neurology Devices) - Global Market Analysis and Forecast Model
|Published by||GlobalData||Product code||646120|
Delivery time: 1-2 business days
|Electrical Activity Testing (Neurology Devices) - Global Market Analysis and Forecast Model|
|Published: May 31, 2018||Content info:||
Electrical Activity Testing (Neurology Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Neurology therapeutic area.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis. Moreover, analyst comments with qualitative insight offer context for quantitative data.
Electrical Activity tests are used to diagnose suspected neurological disorders through Electroencephelograph (EEG), Magnetoencephelograph (MEG) or Electromyograph (EMG) by looking at brain activity. Electroencephelograms (EEG) are used to diagnose issues related to the electrical activity of the brain. EEGs are used to detect various brain-related conditions, including seizures, head injuries, brain tumors, sleep disorders, stroke, and dementia. Electromyograms (EMG) are used to measure muscle activities and nerves in response to electrical activity, and can be used to diagnose muscular or nerve disorders such as muscular dystrophy, and disorders that affect motor neurons or different sections of the nerve. Magnetoencephelogram (MEG) tests are the most advanced method of studying brain activity while actively functioning. MEGs are used to map functional areas (related to motor, language and memory), as well as identify the precise location of epileptic procedures, aiding in the planning of treatment/intervention for patients.
Key Inclusions of the market model
Currently marketed electrical activity testing and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -